Norges Bank
MIRM icon

Norges Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Norges Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-263,175
Closed -$20.8M – 845
2025
Q4 		$20.8M Buy
+263,175
New +$18.9M ﹤0.01% 1221
2024
Q4 		– Sell
-248,157
Closed -$9.68M – 1882
2024
Q3 		$9.68M Buy
+248,157
New +$9.9M ﹤0.01% 1372

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Norges Bank's MIRM Position: Q1 2026 in Review

Norges Bank sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 263,175 shares — an estimated $20.8M sold.

Norges Bank first reported a position in MIRM in Q3 2024 and held it in 2 quarters. The position peaked at $20.8M in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Norges Bank reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 263,175 Mirum Pharmaceuticals shares in Q1 2026, an estimated $20.8M.
  • Norges Bank first reported a position in Mirum Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Norges Bank's Mirum Pharmaceuticals position peaked at $20.8M in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.